Skip to content

Performance Comparison of Masimo O3 Regional Oximetry Sensors in Neonates

Performance Comparison of Masimo O3 Regional Oximetry Sensors in Neonates

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03828487
Enrollment
8
Registered
2019-02-04
Start date
2018-12-19
Completion date
2019-06-14
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Regional Saturation of Oxygen (rSO2)

Brief summary

The aim of the study is to compare the performance of the O3 cerebral oximeter and sensor to a 510(k) cleared NIRS (Near-Infrared Spectroscopy) device on neonatal subjects based on data collected from the cutaneously placed forehead sensors. Due to the design of the systems, the devices will be used serially instead of concurrently. Because of this timing, changes in patient state may not be reflected in measurements collected by both devices.

Interventions

DEVICEMasimo O3 Neonatal Sensors

Regional Oximetry sensor for Neonates

DEVICE510(k) cleared sensor

Cleared Regional Oximetry sensor for Neonates

Sponsors

Masimo Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 28 Days
Healthy volunteers
Yes

Inclusion criteria

* Less than 10 kg * Subjects less than or equal to 28 days old

Exclusion criteria

* Underdeveloped skin at sites of sensor placement * Jaundice or bilirubin levels out of normal range * Subject has skin abnormalities affecting the sensor placement area such as psoriasis, eczema, angioma, scar tissue, burn, fungal infection, or substantial skin breakdown that would prevent monitoring of oxygenation levels during the study * Subject deemed not eligible based on Principal Investigator's judgment

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With rSO2 CollectedData collection period; alternating sensors every 5 minutes for up to 20 minutes.In order to obtain the RMS value, rSO2 values collected from the control device (510(k) cleared regional oximetry sensor) is subtracted from the rSO2 values collected from the investigational device (Masimo O3 neonatal sensors) for a number of samples, the average of this difference is computed as the bias. The standard deviation of the differences is computed as the precision. The square root of the sum of the squares of bias and precision is computed as the RMS Error value.

Countries

United States

Participant flow

Participants by arm

ArmCount
Neonatal Test Group
Subjects will receive a Masimo O3 Neonatal sensors as well as a 510(k) cleared sensor. Masimo O3 Neonatal Sensors: Regional Oximetry sensor for Neonates 510(k) cleared sensor: Cleared Regional Oximetry sensor for Neonates
7
Total7

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyPhysician Decision1

Baseline characteristics

CharacteristicNeonatal Test Group
Age, Categorical
<=18 years
7 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
5 Participants
Region of Enrollment
United States
7 participants
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
4 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 7
other
Total, other adverse events
0 / 7
serious
Total, serious adverse events
0 / 7

Outcome results

Primary

Number of Participants With rSO2 Collected

In order to obtain the RMS value, rSO2 values collected from the control device (510(k) cleared regional oximetry sensor) is subtracted from the rSO2 values collected from the investigational device (Masimo O3 neonatal sensors) for a number of samples, the average of this difference is computed as the bias. The standard deviation of the differences is computed as the precision. The square root of the sum of the squares of bias and precision is computed as the RMS Error value.

Time frame: Data collection period; alternating sensors every 5 minutes for up to 20 minutes.

Population: Study was prematurely terminated. Study did not reach the target number of subjects needed to achieve minimum sample size determination and was insufficient to produce statistically reliable results.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Neonatal Test GroupNumber of Participants With rSO2 Collected7 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026